Posted by Laurence Weider on July 10, 2018
Recent concerns about the potential cancer risks associated with breast implants have led to widespread misinformation. To provide clarity, this article addresses key facts about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), its risks, symptoms, and treatment options, offering a realistic understanding of the condition.
What is BIA-ALCL?
BIA-ALCL is a rare but treatable form of lymphoma that occurs in the tissue surrounding breast implants. It is classified as a cancer of the immune system, distinct from breast cancer.
Who is at Risk?
BIA-ALCL has been primarily linked to textured surface implants. Cases typically develop at least one year, and often several years, after implant placement. Smooth surface implants have not been associated with a confirmed risk of BIA-ALCL.
How Common is BIA-ALCL?
The lifetime risk of developing BIA-ALCL in women with textured implants ranges from 1 in 3,800 to 1 in 30,000. While textured implants represent a small portion of breast implants used, the condition remains extremely rare relative to the number of procedures performed annually.
Symptoms of BIA-ALCL
Symptoms that may indicate BIA-ALCL include:
- Breast Enlargement: Sudden swelling caused by fluid buildup around the implant.
- Pain: Discomfort or tenderness in the breast area.
- Breast Hardening: Increased firmness around the implant.
- Lumps: Noticeable lumps in the breast or armpit.
- Fluid Collection: Accumulation of fluid around the implant.
These symptoms typically appear years after surgery and are limited to patients with textured implants.
What to Do if Symptoms Arise
Patients experiencing symptoms should consult their surgeon promptly for evaluation. Diagnostic steps include:
- Biopsy and Fluid Testing: Fluid around the implant is analyzed for evidence of BIA-ALCL.
- Imaging Scans: CT scans or similar methods are used to determine if the disease has spread.
Early detection and treatment are critical to achieving successful outcomes.
Treatment Options for BIA-ALCL
In most cases, BIA-ALCL is treated by surgically removing the implant and the surrounding scar capsule. This procedure is curative in the majority of patients. If the disease has spread, chemotherapy may be required as part of the treatment plan.
Does Weider Plastic Surgery Use Textured Implants?
We never use textured implants. My practice only employs smooth surface implants, which are not associated with an increased risk of BIA-ALCL. This approach reflects a commitment to minimizing risks while providing safe and effective outcomes for patients.
Key Statistics About Breast Implants and BIA-ALCL
- Annual Breast Implant Procedures in the U.S.: Approximately 550,000, including both cosmetic and reconstructive surgeries.
- Textured Implant Usage: About 70,000 implants annually.
- Reported BIA-ALCL Cases: Fewer than 100 cases each year.
These figures underscore the rarity of BIA-ALCL, particularly when compared to the widespread use of breast implants.
Conclusion: Informed Decisions for Breast Implant Patients
BIA-ALCL is a rare condition, but understanding its risks and symptoms is essential for individuals considering or already living with breast implants. By consulting with qualified surgeons, patients can explore implant options, discuss associated risks, and receive professional guidance tailored to their specific needs. Accurate information and proactive monitoring allow for confident decision-making and optimal care.
Dr. Weider, a native of Southern California, is a Board-Certified Plastic Surgeon who has maintained a private practice in Dallas, TX since 1999. After attending Stanford University, he obtained his medical degree (M.D.) from Baylor College of Medicine in Houston. He then completed a one year surgical internship in Los Angeles at Harbor-UCLA Medical Center, followed by a four year general surgery residency in Dallas at Methodist Medical Center, and a two year plastic surgery fellowship in Cleveland at Case Western Reserve University.
